N1 Chewables
Tikun Olam |
N1 - Chewables
Neurological support and inflammation relief cannabis-infused chewables.
Provides gentle daily support for neurological and inflammatory conditions in an easy, low-dose format.
15:1 CBD:THC
15 mg CBD + 1 mg THC per serving
20 servings total
Dosing: Fixed dose
Full-spectrum, live-resin oil
Made with Tikun Olam’s proprietary Avidekel strain.
Naturally flavored with real fruit juice.
Vegan and suitable for daily use.
Consistent cannabinoid and terpene profile.
Some individuals may experience a mild sense of euphoria.
Chewables
Tikun Olam’s N1 vegan chewables are formulated with pharmaceutical-grade precision and plant-based purity. They provide reliable daily support for neurological and inflammatory symptoms with a consistent cannabinoid and terpene profile.
What is N1?
N1 is a CBD-rich 15:1 CBD:THC formula designed to help manage neurological discomfort and reduce inflammation throughout the body. Developed from Tikun Olam’s highly researched Avidekel strain in collaboration with Dr. Raphael Mechoulam, N1 is supported by clinical trials for therapeutic use.
Supports relief from neurological and inflammatory conditions.
Backed by peer-reviewed clinical research.
Derived from Tikun Olam’s proprietary Avidekel strain.
With deep roots in Israel, we are proud pioneers and global leaders in medical cannabis research and development. We trace our world-leading research history to visionaries such as Professor Rafael Mechoulam, the “father of cannabis research,” and Israel’s other top scientists, universities, and hospitals. We continually perform government-regulated clinical studies on a spectrum of unique cannabis strains. It’s how we’ve built the world’s largest medical cannabis treatment database – 20,000 patient records and growing. In Hebrew, "Tikun Olam" translates to "repair the world. “It guides Tikun’s mission to improve lives of those suffering from debilitating conditions, with innovative strains backed by our unmatched foundation in science.
With 15 years of experience, Tikun is a recognized global pioneer and leader in medical cannabis research drawing upon the knowledge of top experts in the areas of cannabis cultivation, research, operations and product development. The company continually examines the effects its strains and products have in the treatment and management of specific symptoms and diseases. Tikun is committed to product quality and wellness, and cultivates only premium cannabis in the lab and in the field with its business partners to ensure the consistency of its medical cannabis products.
Tikun’s scientists and cultivators have developed exclusive proprietary strains designed to bring therapeutic relief and quality of life improvements to patients and their families. Based on years of extensive research, Tikun’s strains and products have been devised to address a variety of patient maladies, including pain reduction, loss of appetite, inflammation, nausea, dementia, and insomnia among other conditions. The company continues to collaborate with scientists, universities and hospitals participating in medical studies on the use of cannabis, its effects and therapeutic benefits.
We strive to improve lives of those struggling with pain and debilitating conditions, and those simply seeking a greater sense of well being. It follows the ancient concept of Tikun Olam, meaning, “repair the world.” We honor that directive by pioneering medical cannabis research and cultivation that serves patients around the globe.